CONMED (NYSE:CNMD) Upgraded to Hold at Zacks ResearchMarket Beat·Aug 13 at 06:36 AMCNMD+0.02%FITB-0.54%
Capital Diverges as AI Infra Pushes Higher While Micro-Caps Face Delisting PressuresGlobal Report·Aug 4 at 04:17 AMWINT0.00%BN-1.45%
CONMED Q2 FY26 adjusted EPS rises 20% to $1.38; net sales increase 0.3% to $343.5 millionPUBT·Jul 29 at 03:27 PMCNMD+0.02%
Conmed | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 343.49 MEarnings Watch·Jul 29 at 03:23 PMCNMD+0.02%
CNMD: Q2 2026 delivered 6.0% organic sales growth and 20% higher adjusted EPS, with updated full-year guidanceQuartr·Jul 29 at 03:11 PMCNMD+0.02%
CONMED Corporation to Participate in the Society of Robotic Surgery Annual MeetingUnusual Whales·Jul 20 at 06:07 AMCNMD+0.02%
Conmed Surges Within Striking Distance Of A Breakout On Buyout RumorsUnusual Whales·Jul 13 at 12:16 PMCNMD+0.02%
